|
Volumn 8, Issue 3-4, 2000, Pages 231-236
|
Neuroprotective aspects of a novel MAO-B inhibitor PF9601N
a
a
a
a
|
Author keywords
Antioxidative; MAO B inhibitor; Neuroprotection
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
ANTIOXIDANT;
DOPAMINE;
METHYLAMINE;
MONOAMINE OXIDASE B INHIBITOR;
N (2 PROPINYL) 2 (5 BENZYLOXYINDOL)METHYLAMINE;
PF 9601N;
SELEGILINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
AUTOOXIDATION;
CONTROLLED STUDY;
DOPAMINE RELEASE;
DRUG SELECTIVITY;
IN VITRO STUDY;
IN VIVO STUDY;
MALE;
MOUSE;
NEUROPROTECTION;
NONHUMAN;
PARKINSON DISEASE;
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE;
ANIMALS;
CORPUS STRIATUM;
DISEASE MODELS, ANIMAL;
DOPAMINE;
DOPAMINE AGENTS;
INDOLES;
MALE;
METHYLAMINES;
MICE;
MICE, INBRED C57BL;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
NEUROPROTECTIVE AGENTS;
PARKINSONIAN DISORDERS;
SELEGILINE;
|
EID: 0034480318
PISSN: 12168068
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (8)
|